The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction

NCT07103655 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Hypertrophic Cardiomyopathy (HCM)

Interventions

DRUG: mavacamten
DRUG: Beta Blocker (BB) - metoprolol, bisoprolol, carvedilol
DRUG: diltiazem

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University